Add to ORKGTitle from cover. "May, 1998." "#4020-98-MSA"Includes bibliographical references (p. 41-43).Martin U. Grossmann
Using the framework of the business model developed in Rasmussen (2007b) this paper presents an outl...
This paper explored an unusually comprehensive dataset of more than 2,000 drug R&D projects all over...
Patents are especially important for the business of drug discovery; however, their importance for b...
Purpose Using a dynamic capabilities lens, this paper aims to study the impact of genomics generally...
Since the 2000s, the Pharmaceutical industry has been facing strong challenges: a constantly changin...
The emergence of new fundamental knowledge in life sciences is leading to new, "breakthrough" techno...
Thesis (M.S.)--Massachusetts Institute of Technology, Sloan School of Management, 1996.Includes bibl...
There is a growing gap in productivity in the biopharmaceutical industry. The money spent on develop...
The top managers of a biotechnology startup firm agreed to participate in a system dynamics modeling...
The top managers of a biotechnology startup firm agreed to participate in a system dynamics modeling...
The top managers of a biotechnology startup firm agreed to participate in a system dynamics modeling...
The pharmaceutical industry has been criticized for not availing more innovative medicines for treat...
The top managers of a biotechnology startup firm agreed to participate in a system dynamics modeling...
The biotechnology and pharmaceutical industries are facing significant challenges to their existing ...
Policy research examines, among other things, factors related to the development and review of new d...
Using the framework of the business model developed in Rasmussen (2007b) this paper presents an outl...
This paper explored an unusually comprehensive dataset of more than 2,000 drug R&D projects all over...
Patents are especially important for the business of drug discovery; however, their importance for b...
Purpose Using a dynamic capabilities lens, this paper aims to study the impact of genomics generally...
Since the 2000s, the Pharmaceutical industry has been facing strong challenges: a constantly changin...
The emergence of new fundamental knowledge in life sciences is leading to new, "breakthrough" techno...
Thesis (M.S.)--Massachusetts Institute of Technology, Sloan School of Management, 1996.Includes bibl...
There is a growing gap in productivity in the biopharmaceutical industry. The money spent on develop...
The top managers of a biotechnology startup firm agreed to participate in a system dynamics modeling...
The top managers of a biotechnology startup firm agreed to participate in a system dynamics modeling...
The top managers of a biotechnology startup firm agreed to participate in a system dynamics modeling...
The pharmaceutical industry has been criticized for not availing more innovative medicines for treat...
The top managers of a biotechnology startup firm agreed to participate in a system dynamics modeling...
The biotechnology and pharmaceutical industries are facing significant challenges to their existing ...
Policy research examines, among other things, factors related to the development and review of new d...
Using the framework of the business model developed in Rasmussen (2007b) this paper presents an outl...
This paper explored an unusually comprehensive dataset of more than 2,000 drug R&D projects all over...
Patents are especially important for the business of drug discovery; however, their importance for b...